Table 2.
Scheme of the experiment of introduction GQIcombi (bi-(AID-1-T) + SB431542, LDN-193189, purmorphamine, and BDNF) into rat glioma 101/8.
| Day of therapy after tumor implantation | Factor and dose |
|---|---|
| 8 | bi-(AID-1-T)– 37,5 µМ |
| 9 | bi-(AID-1-T) – 37,5 µМ + SB431542 (20 µМ) + LDN-193189 (2 µМ) |
| 10 | SB431542 (20 µМ) + LDN-193189 (2 µМ) + purmorphamine (4 µМ) |
| 11 | purmorphamine (4 µМ) + BDNF (40 ng/ml) |